Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Gold’s Meteoric Ascent: The $4,000 Threshold Beckons

Robert Sasse by Robert Sasse
October 7, 2025
in Commodities, Gold & Precious Metals, Market Commentary
0
Goldbarren Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

The precious metal is charging toward the psychologically significant $4,000 per ounce milestone, having already established a fresh all-time high of $3,977.19. This remarkable rally, which has seen gold surge 51 percent year-to-date, is being fueled by a combination of political instability in the United States and growing anticipation of interest rate cuts, reinforcing its status as a premier safe-haven asset.

Government Gridlock and Monetary Policy Fuel Demand

A deepening political crisis in Washington is creating substantial market unease. With no clear resolution in sight for the legislative standoff between the two houses of Congress, the publication of critical economic data—including September’s jobs report—has been suspended. This climate of uncertainty is driving a direct flight to safety, with investors increasingly allocating capital to gold.

Market pricing now indicates a 95 percent probability of a 25-basis-point rate cut in October, with an 83 percent chance priced in for a similar move in December. Kelvin Wong, an analyst at OANDA, notes, “The odds for both October and December rate reductions remain above the 80 percent threshold, providing a solid foundation for gold’s strength.”

Should investors sell immediately? Or is it worth buying Goldbarren?

Goldman Sachs Lifts Its Long-Term Forecast

In a significant revision, the investment bank Goldman Sachs has sharply increased its gold price projection for December 2026, raising it from $4,300 to $4,900 per ounce. This optimistic outlook is supported by several powerful drivers:

  • Sustained Central Bank Purchases from institutions worldwide
  • Rising ETF Demand from institutional investors
  • A Weakening US Dollar amid expectations for a more accommodative monetary policy
  • Ongoing Geopolitical Strains amplifying safe-haven appeal

Gold, which offers no yield, stands to benefit considerably from a lower interest rate environment. This dynamic is not uniformly shared across the precious metals complex; silver recently edged down 0.1 percent to $48.49, while platinum declined 0.4 percent to $1,619.62.

A Clear Path to Higher Ground

Market experts see a clear trajectory for gold to challenge the $4,000 level. The powerful confluence of political paralysis, anticipated monetary easing, and persistent investor appetite is likely to continue propelling the metal. As long as the US government crisis remains unresolved and key economic indicators are unavailable, gold is poised to capitalize on its role as the ultimate currency in times of turmoil.

Ad

Goldbarren Stock: Buy or Sell?! New Goldbarren Analysis from February 7 delivers the answer:

The latest Goldbarren figures speak for themselves: Urgent action needed for Goldbarren investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Goldbarren: Buy or sell? Read more here...

Tags: Goldbarren
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Communications Stock
Industrial

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Next Post
Commerzbank Stock

Commerzbank Launches Major Share Buyback Program

Silber Stock

Silver's Meteoric Ascent: Unpacking the Rally Beyond $48

Omv Stock

OMV's Strategic Pivot: Austerity and Gas Focus Reshape Investment Outlook

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com